UK Diabetes Inpatient Forum unveil agenda for forthcoming national conference
A sparkling line-up of leading healthcare professionals will form part of the exciting agenda for the UK Diabetes Inpatient Forum’s first national conference, organisers have revealed.
Taking place on Thursday, January 27, the online event will celebrate 100 years since insulin was first administered to a human.
Virtual attendees will first be greeted by Consultant Diabetologist Professor Gerry Rayman, who is chairing the national conference.
Dr Mayank Patel, Consultant in Diabetes and Acute Medicine, and Professor Partha Kar OBE, National Specialty Advisor for Diabetes will provide an overview of their comic book project during the first speaker presentation.
The pair will briefly touch on volume two of the comics, ‘attack of the ketones’, which sees a character hospitalised with diabetic ketoacidosis (DKA), but an error occurs during her treatment, highlighting the potential risks that can occur in hospital for those with type 1 diabetes if insulin is delayed or missed.
Session two will see June James, Independent Nurse Consultant and Co-Chair of Trend Diabetes, will look at the evolution of insulin by exploring the impact of technological advancements.
June said: “On this 100th anniversary of the use of insulin, it is important to review just how care using this treatment has changed.
“Over the last century, there has been significant innovation in the type and action of different insulins and how insulin is delivered.”
She added: “With change, however, comes risks of insulin error. These are frequently related to the prescribing, preparation, and delivery of insulin therapy.”
Halfway through the event, Erwin Castro, Diabetes Nurse Consultant, will chair a symposium on the relationship between an ageing population and diabetes, with Diabetes Specialist Nurse Jane Rowney announced as the speaker.
Alongside chairing the entire conference, Prof Rayman will also be speaking about how insulin therapy has advanced during the course of his career.
Prof Rayman will discuss how insulin therapy has evolved throughout the years, particularly glass syringes, steel needles, hybrid closed loop systems and stem cell therapy.
Diabetes and Endocrinology Consultant, Professor Ketan Dhatariya will close the speaker presentations with his session ;The history of Diabetic Ketoacidosis’.
Recognised as the world’s top expert for diabetic ketoacidosis, Prof Dhatariya will explore the early studies on the management of DKA and how they have led to the current guidelines.
He said: “There remain many areas of uncertainty and it may be argued that the ADA guidelines are no longer fit for purpose.
“There are few studies ongoing to help inform clinical practice; however, with the availability of IT and large data gathering capability, there is new hope that evidence will inform the next versions of the guidelines rather than expert opinion. The outlook for the management of DKA looks good.”
Registered delegates will have the opportunity to attend every session and will be able to ask questions to each speaker at the end of their presentation.
The UK Diabetes Inpatient Forum was established to share best practice and the latest developments and research in diabetes inpatient care. Its mission is to provide high-quality education for professionals to improve inpatient care for people with diabetes.
Novo Nordisk has provided sponsorship to the ‘100 Years of Insulin Conference 2022’ to cover the development costs of project administration and management.
Novo Nordisk has had no influence over the creation, development or content of the ‘100 Years of Insulin Conference 2022’ and full control remains the full responsibility of the UK Diabetes Inpatient Forum.